The American Hospital Association argues new policies from Eli Lilly and Novo Nordisk requiring providers to submit more ...

A new Ohio bill won't expand the 340B program, but it will protect patients' ability to fill prescriptions at their pharmacy of choice.

A new report paints a stark picture of how a subset of large healthcare providers are drawing the lion’s share of 340B savings within a single state.  | A Minnesota analysis of providers' reported ...

The hospital lobby is asking federal officials to head off expanded data collection policies some drugmakers are implementing for providers participating in the 340B drug discount program.

The 340B program requires pharmaceutical manufacturers to sell drugs at significant discounts — in some cases, extremely steep discounts — to hospitals and clinics serving large numbers of uninsured ...

AHA urges HHS to block Novo Nordisk's 340B data demand, citing legal and cost concerns for safety-net hospitals and covered entities.

AHA letter to the Health Resources and Services Administration about a new concerning development with the 340B Program.

AbbVie loses bid to block Tennessee 340B law as federal court upholds state statute limiting drugmaker restrictions on contract pharmacies.

The AHA March 3 urged the Health Resources and Services Administration to take immediate action to stop a new Novo Nordisk ...

Hospitals and contract pharmacies are not required to pass those savings directly to patients at the pharmacy counter. | ...

The Washington state House Appropriations Committee has advanced a bill concerning a federal drug pricing program known as the 340B Program that one committee member described as a “a cash grab for ...

The 340B Drug Pricing Program was created to help a targeted group of safety net providers care for low-income and uninsured patients. First enacted as part of the Veterans Healthcare Act of 1992, ...